These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8096550)

  • 1. [Loss of heterozygosity in hepatocellular carcinoma].
    Takahashi K; Kudo J; Ishibashi H; Niho Y
    Nihon Rinsho; 1993 Feb; 51(2):370-4. PubMed ID: 8096550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma.
    Takahashi K; Kudo J; Ishibashi H; Hirata Y; Niho Y
    Hepatology; 1993 May; 17(5):794-9. PubMed ID: 8387946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan.
    Sheu JC; Lin YW; Chou HC; Huang GT; Lee HS; Lin YH; Huang SY; Chen CH; Wang JT; Lee PH; Lin JT; Lu FJ; Chen DS
    Br J Cancer; 1999 May; 80(3-4):468-76. PubMed ID: 10408855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of somatic heterozygosity in hepatocellular carcinoma.
    Walker GJ; Hayward NK; Falvey S; Cooksley WG
    Cancer Res; 1991 Aug; 51(16):4367-70. PubMed ID: 1678314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelotype study of primary hepatocellular carcinoma.
    Fujimori M; Tokino T; Hino O; Kitagawa T; Imamura T; Okamoto E; Mitsunobu M; Ishikawa T; Nakagama H; Harada H
    Cancer Res; 1991 Jan; 51(1):89-93. PubMed ID: 1670995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer.
    Emi M; Fujiwara Y; Nakajima T; Tsuchiya E; Tsuda H; Hirohashi S; Maeda Y; Tsuruta K; Miyaki M; Nakamura Y
    Cancer Res; 1992 Oct; 52(19):5368-72. PubMed ID: 1356616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors.
    Okabe H; Ikai I; Matsuo K; Satoh S; Momoi H; Kamikawa T; Katsura N; Nishitai R; Takeyama O; Fukumoto M; Yamaoka Y
    Hepatology; 2000 May; 31(5):1073-9. PubMed ID: 10796882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype.
    Boige V; Laurent-Puig P; Fouchet P; Fléjou JF; Monges G; Bedossa P; Bioulac-Sage P; Capron F; Schmitz A; Olschwang S; Thomas G
    Cancer Res; 1997 May; 57(10):1986-90. PubMed ID: 9157995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity on chromosome 16 in hepatocellular carcinoma.
    Sakai K; Nagahara H; Abe K; Obata H
    J Gastroenterol Hepatol; 1992; 7(3):288-92. PubMed ID: 1351753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas.
    Slagle BL; Zhou YZ; Butel JS
    Cancer Res; 1991 Jan; 51(1):49-54. PubMed ID: 1670994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytogenetic and molecular genetic alterations on chromosome 4q in human hepatocellular carcinoma].
    Zhang HK; Wang HY; Xia JC
    Ai Zheng; 2008 Sep; 27(9):998-1005. PubMed ID: 18799044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between loss of heterozygosity of tumor suppressor genes and histologic differentiation in hepatocellular carcinoma.
    Piao Z; Kim H; Jeon BK; Lee WJ; Park C
    Cancer; 1997 Sep; 80(5):865-72. PubMed ID: 9307185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion mapping of chromosome 16q in hepatocellular carcinoma.
    Piao Z; Park C; Kim JJ; Kim H
    Br J Cancer; 1999 May; 80(5-6):850-4. PubMed ID: 10360665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelotype of renal cell carcinoma.
    Morita R; Ishikawa J; Tsutsumi M; Hikiji K; Tsukada Y; Kamidono S; Maeda S; Nakamura Y
    Cancer Res; 1991 Feb; 51(3):820-3. PubMed ID: 1670999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma.
    Zhang WD; Hirohashi S; Tsuda H; Shimosato Y; Yokota J; Terada M; Sugimura T
    Jpn J Cancer Res; 1990 Feb; 81(2):108-11. PubMed ID: 1970554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Accumulation of genetic alterations during human tumor progression].
    Yokota J; Ookawa K
    Gan To Kagaku Ryoho; 1993 Feb; 20(3):321-5. PubMed ID: 8094949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic and molecular genetic alterations in hepatocellular carcinoma.
    Lau SH; Guan XY
    Acta Pharmacol Sin; 2005 Jun; 26(6):659-65. PubMed ID: 15916730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent loss of heterozygosity at the Hcr1 (hepatocarcinogenesis resistance) locus on chromosome 10 in primary hepatocellular carcinomas from LFF1 rat strain.
    De Miglio MR; Muroni MR; Simile MM; Virdis P; Asara G; Frau M; Calvisi DF; Seddaiu MA; Pascale RM; Feo F
    Hepatology; 2001 May; 33(5):1110-7. PubMed ID: 11343238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas.
    Sano T; Tsujino T; Yoshida K; Nakayama H; Haruma K; Ito H; Nakamura Y; Kajiyama G; Tahara E
    Cancer Res; 1991 Jun; 51(11):2926-31. PubMed ID: 2032230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays.
    Midorikawa Y; Yamamoto S; Ishikawa S; Kamimura N; Igarashi H; Sugimura H; Makuuchi M; Aburatani H
    Oncogene; 2006 Sep; 25(40):5581-90. PubMed ID: 16785998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.